Abstract
Inflammatory cardiomyopathy defined as myocarditis associated with cardiac dysfunction, represents a main cause of heart failure. Despite the improvement of diagnostic techniques, a specific standardized treatment of myocarditis is not yet available. The immunohistochemical detection of myocardial HLA up-regulation has been demonstrated useful in the identification of a subgroup of autoimmune inflammatory dilated cardiomyopathy (DCM) in part susceptible to immunosuppression. Recently, in a retrospective study, we de- fined the virologic and immunologic profile of responders and non-responders to immunosuppressive therapy of active lymphocytic myocarditis and chronic heart failure in patients who had failed to benefit from conventional supportive treatment. Non-responders were characterized by high prevalence (85%) of viral genomes in the myocardium and no detectable cardiac autoantibodies in the serum. Conversely, 90% of responders were positive for autoantibodies, while only 3 (15%) of them presented viral particles at PCR analysis on frozen endomyocardial tissue. With regard to the type of virus involved in nonresponders, enterovirus, adenovirus, or their combination was associated with the worst clinical outcome. Hepatitis C virus (HCV) was the only viral agent of our series associated with detectable cardiac autoantibodies, suggesting a relevant immunomediated mechanism of damage by HCV and explaining the relief of myocardial inflammation after immunosuppressive treatment. The assessment of virologic and immunologic features of patients with biopsy-proven inflammatory cardiomyopathy may allow us to identify a specific treatment leading to recovery of cardiac function.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Angelini A, Calzolari V, Calabrese F, et al. (2000) Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart 84:245–250
Aretz H, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, Olsen EGJ, Schoen F (1986) Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1:3–14
Badorff C, Schwimmbeck PL, Kühl U, et al. (1997) Cardiac sarcoidosis: diagnostic validation by endomyocardial biopsy and therapy with corticosteroids. Z Kardiol 86:9–14
Badorff C, Lee GH, Lamphear BJ, et al. (1999) Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5:320–326
Billingham ME (1997) Can histopathology guide immunosuppression for cardiac allograft rejection in the light of new techniques? Transplant Proc 29:35S–36S
Chan KY, Iwahara A, Benson LN, et al. (1991) Immunosuppressive therapy in the management of acute myocarditis in children; a clinical trial. J Am Coll Cardiol 17:458–460
Chimenti C, Calabrese F, Thiene G, et al. (2001) Inflammatory left ventricular microaneurysms as a cause of apparently idiopathic ventricular tachyarrhythmias. Circulation 104:168–173
Chimenti C, Russo A, Pieroni M, Calabrese F, Verardo R, Russo MA, Maseri A, Frustaci A (2004) Intramyocyte detection of Epstein Barr virus genome by laser capture microdissection in patients with inflammatory cardiomyopathy. Circulation 110:3534–3539
Cooper LT Jr, Berry GJ, Shabetai R (1997) Idiopathic giant-cell myocarditisnatural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 336:1860–1866
Dec GW Jr, Palacios IF, Fallon JT, et al. (1985) Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med 312:885–890
Feldman AM, McNamara D (2000) Myocarditis. N Engl J Med 343:1388–1398
Frustaci A, Gentiloni N, Caldarulo M (1996) Acute myocarditis and left ventricular aneurysm as presentations of systemic lupus erythematosus. Chest 109:282–284
Frustaci A, Gentiloni N, Chimenti C, et al. (1998) Necrotizing myocardial vasculitis in Churg-Strauss syndrome: clinicohistologic evaluation of steroids and immunosuppressive therapy. Chest 114:1484–1489
Frustaci A, Chimenti C, Maseri A (1999) Global bi-ventricular dysfunction in patients with symptomatic coronary artery disease may be caused by myocarditis. Circulation 99:1295–1299
Frustaci A, Chimenti C, Pieroni M, et al. (2000) Giant cell myocarditis responding to immunosuppressive therapy. Chest 117:905–907
Frustaci A, Chimenti C, Calabrese F, Pieroni M, et al. (2003) Active lymphocytic myocarditis: virologic and immunologic profile of responders vs non-responders to immunosuppressive therapy. Circulation 107:857–863
Gjerdrum LM, Lielpetere I, Rasmussen LM, et al. (2001) Laser-assisted microdissection of membrane-mounted paraffin sections for polymerase chain reaction analysis. Identification of cell populations using immunohistochemistry and in situ hybridization. J Mol Diagn 3:105–110
Kleinert S, Weintraub RG, Wilkinson JL, et al. (1997) Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression. J Heart Lung Transplant 16:1248–1254
Kühl U, Schultheiss HP (1995) Treatment of chronic myocarditis with corticosteroids. Eur Heart J 16Suppl O:168–172
Kühl U, Seeberg B, Schultheiss HP, et al. (1994) Immunohistological characterization of infiltrating lymphocytes in biopsies of patients with clinically suspected dilated cardiomyopathy. Eur Heart J 15:62–67
Kühl U, Pauschinger M, Schwimmbeck PL, et al. (2003) Interferon-β treatment of patients with enteroviral and adenoviral cardiomyopathy causes effective virus clearance and long-term clinical improvement. Circulation 107:2793–2798
Lee KJ, McCrindle BW, Bohn DJ, et al. (1999) Clinical outcomes of acute myocarditis in childhood. Heart 82:226–233
Martin AB, Webber S, Fricker FJ, et al. (1994) Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 90:330–339
Mason JW, O’Connell JB, Herskowitz A, et al. (1995) A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 333:269–275
Matitiau A, Perez-Atayde A, Sanders SP, et al. (1994) Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation 90:1310–1318
Narula J, Khaw BA, Dec GW Jr, et al. (1993) Brief report: recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med 328:100–104
Noutsias M, Fechner H, de Jonge H, et al. (2001) Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation 104:275–280
Parrillo JE, Cunnion RE, Epstein SE, et al. (1989) A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 321:1061–1068
Pauschinger M, Bowles NE, Fuentes-Garcia FJ, Pham V, Kühl U, Schwimmbeck PL, Schultheiss HP, Towbin JA (1999a) Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99:1348–1354
Pauschinger M, Doerner A, Kuehl U, et al. (1999b) Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 99:889–895
WHO/ISFC (1996) Report of the 1995 WHO/ISFC task force on the definition and classification of cardiomyopathies. Circulation 93:841–842
Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al. (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104:39–45
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Frustaci, A., Pieroni, M., Chimenti, C. (2006). Immunosuppressive Treatment of Chronic Non-viral Myocarditis. In: Schultheiss, H.P., Kapp, J.F., Grötzbach, G. (eds) Chronic Viral and Inflammatory Cardiomyopathy. Ernst Schering Research Foundation Workshop, vol 55. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-30822-9_19
Download citation
DOI: https://doi.org/10.1007/3-540-30822-9_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23971-0
Online ISBN: 978-3-540-30822-5
eBook Packages: MedicineMedicine (R0)